Skip to main content
Clinical Trials/NCT03403842
NCT03403842
Unknown
Not Applicable

Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections

IRCCS San Raffaele1 site in 1 country159 target enrollmentFebruary 1, 2018

Overview

Phase
Not Applicable
Intervention
Peridural catheter
Conditions
Analgesia
Sponsor
IRCCS San Raffaele
Enrollment
159
Locations
1
Primary Endpoint
Pain intensity change in the post-operative period depending on the adopted analgesic treatment
Last Updated
7 years ago

Overview

Brief Summary

Objective of the study is to compare three different analgesic techniques in patients undergoing laparoscopic colon resections: peridural catheter, patient controlled analgesia of endovenous morphine and patient controlled analgesia of sufentanil sublingual tablets.

Detailed Description

159 patients undergoing laparoscopic colon resections will be enrolled and randomized in three different groups. Patients in the first group will be subjected to the positioning of a peridural catheter with a continuous infusion of ropivacaine 0,2%99 ml+sufentanil 50 mcg at an infusion rate of 4-6 ml/h. In the second group participants will receive an intraoperative bolus of morphine (0,05mg/kg) and post-operatively a patient controlled analgesia of endovenous morphine (injection dose 1 mg,lock-out 10 minutes,maximum morphine dosage for hour 4 mg). In the third group the investigators will adopt an intraoperative bouls of morphine (0,05mg/kg) and post-operatively a patient controlled analgesia of sufentanil sublingual tablets( 15 mcg, lock-out 20 minutes)

Registry
clinicaltrials.gov
Start Date
February 1, 2018
End Date
August 1, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marco Gemma

Principal Investigator

IRCCS San Raffaele

Eligibility Criteria

Inclusion Criteria

  • Age\>18 Patients undergoing laparoscopic colon resections/ Acceptance informed consent

Exclusion Criteria

  • Contraindications to the positioning of a peridural catheter/ Previous allergic reactions to the drugs used in the study/ inability of using patient controlled analgesia system

Arms & Interventions

PERIDURAL

Peridural catheter positioning with a continuous infusion of ropivacaine 0,2% 99 ml+ sufentanil 50 mcg at an infusion rate of 4-6 ml/h

Intervention: Peridural catheter

PCA MORPHINE

Patient controlled analgesia of endovenous morphine, injection dose 1 mg, lock-out time 10 minutes, maximum dosage for hour 4 mg

Intervention: PCA Morphine

SSTS

Patients controlled analgesia of sublingual sufentanil tablet system, 15 mcg sufentanil tablets, lock out time 20 minutes

Intervention: Sublingual sufentanil tablet system

Outcomes

Primary Outcomes

Pain intensity change in the post-operative period depending on the adopted analgesic treatment

Time Frame: NRS will be evaluated in recovery room at 30 minutes after the end of surgery and at 6-24-48-72 hours after the end of surgery or until to the end of the proposed analgesic treatment

The intensity of acute post-operative pain will be evaluated ,according NRS(numerical rating scale) by our Acute pain Service.NRS is a 11 point scale for patient self-reporting of pain, where zero represents no pain and ten is considered as the worst pain ever possible

Secondary Outcomes

  • Side effects(The onset of possible side effects will be monitored from randomization until to the end of the proposed analgesic treatment, assessed up to 72 hours)

Study Sites (1)

Loading locations...

Similar Trials